Maurizio Cutolo

Research interests

Publications

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

  Annals of the Rheumatic Diseases · 2022 · https://doi.org/10.1136/ard-2022-223356

• The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis

  Frontiers in Immunology · 2022 · 10.3389/fimmu.2022.867260

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

  Annals of the Rheumatic Diseases · 2020 · https://doi.org/10.1136/annrheumdis-2019-216655

• Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis

  Autoimmunity Reviews · 2020 · 10.1016/j.autrev.2020.102458

• Pathophysiology of systemic sclerosis: current understanding and new insights

  Expert Review of Clinical Immunology · 2019 · 10.1080/1744666x.2019.1614915

• Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review

  Autoimmunity Reviews · 2019 · 10.1016/j.autrev.2019.102397

• Mapping and predicting mortality from systemic sclerosis

  Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2017-211448

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

  Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2016-210715

• European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes

  Journal of the European Academy of Dermatology and Venereology · 2017 · https://doi.org/10.1111/jdv.14458

• Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2015-208916

• European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2015-208337

• Update of EULAR recommendations for the treatment of systemic sclerosis

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209909

• The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

  Annals of the Rheumatic Diseases · 2016 · 10.1136/annrheumdis-2015-208840

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

  Annals of the Rheumatic Diseases · 2013 · https://doi.org/10.1136/annrheumdis-2013-204573

• Epidemiology of chronic musculoskeletal pain

  Best Practice & Research Clinical Rheumatology · 2011 · 10.1016/j.berh.2010.01.012

• Phase IIb dose‐ranging study of the oral JAK inhibitor tofacitinib (CP‐690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease‐modifying antirheumatic drugs

  Arthritis & Rheumatism · 2011 · 10.1002/art.33383

• Energy regulation and neuroendocrine–immune control in chronic inflammatory diseases

  Journal of Internal Medicine · 2010 · 10.1111/j.1365-2796.2010.02218.x

• Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

  Annals of the Rheumatic Diseases · 2010 · https://doi.org/10.1136/ard.2010.136929

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

  Annals of the Rheumatic Diseases · 2010 · https://doi.org/10.1136/ard.2009.126532

• Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study

  Arthritis Research & Therapy · 2009 · 10.1186/ar2591

• EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

  Annals of the Rheumatic Diseases · 2007 · https://doi.org/10.1136/ard.2007.072157

• Physical inactivity in patients with rheumatoid arthritis: Data from twenty‐one countries in a cross‐sectional, international study

  Arthritis Care & Research · 2007 · 10.1002/art.23255

• Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients

  Annals of the Rheumatic Diseases · 2007 · 10.1136/ard.2007.079756

• Estrogens and Autoimmune Diseases

  Annals of the New York Academy of Sciences · 2006 · 10.1196/annals.1386.043

• Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity

  Lupus · 2004 · 10.1191/0961203304lu1094oa

• Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis

  Lara D. Veeken · 2004 · 10.1093/rheumatology/keh156

Current projects

No projects listed.